Skip to content
Screener

Merck & Co. MRK Common Stock Par Value Per Share

Common Stock Par Value Per Share at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$0.000.0%
Zoetis logo
ZoetisZTS
$0.010.0%
Vaxcyte, Inc. logo
Vaxcyte, Inc.PCVX
$0.000.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0.000.0%
Summit Therapeutics logo
Summit TherapeuticsSMMT
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE

Other financials

Income statement

See full
Revenue$16.6B+5.1%
Gross profit$12.2B-0.3%
Net income-$1.3B-130%
EPS (diluted)-$0.54-131%

Balance sheet

See full
Cash & equivalents$6.9B-14.6%
Total debt$56.7B+54.0%
Total equity$41.9B-14.4%
Total assets$129.80B+10.4%

Cash flow

See full
Operating cash flow$5.4B+63.1%
CapEx$893.0M+16.9%
Free cash flow$4.5B+77.0%

Valuation

See full
Market cap$317.05B+59.8%
Enterprise value$366.89B+61.5%
P/E99.9×+87.8×
P/S4.8×+1.6×

Profitability

See full
Gross margin73%-3.6pp
Net margin4.8%-21.0pp
FCF margin24.1%+1.0pp

Returns & leverage

See full
Return on equity7%-28.5pp
Debt / equity1.4×+0.6×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:11 PM EDT
Fiscal quarter
Q3 FY2028
Calendar quarter
Q3 2028
Accession
0000310158-26-000212
Line itemJune 30, 2026December 31, 2025
Deferred Income Taxes1,4331,439
Other Noncurrent Liabilities7,5737,688
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par valueAuthorized - 6,500,000,000 sharesIssued - 3,577,103,522 shares in 2026 and 20251,7881,788
Other paid-in capital44,95045,029
Retained earnings63,26973,075
Accumulated other comprehensive loss(3,942)(4,287)
106,065115,605

Item 1. Financial Statements

FAQ

What is Merck & Co.'s common stock par value per share?
Merck & Co. (MRK) reported common stock par value per share of $0.50 in Q2 2026.
How has Merck & Co.'s common stock par value per share changed year-over-year?
Merck & Co.'s common stock par value per share decreased by 0.0% year-over-year, from $0.50 to $0.50.
What is the long-term trend for Merck & Co.'s common stock par value per share?
Over 5 years (2020 to 2025), Merck & Co.'s common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.50 to $0.50.
What does common stock par value per share mean?
The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.

Ask your AI about Merck & Co.'s common stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude